Evidence map›Paper›PMID 40286066›Full record

ArticleMolecules (Basel, Switzerland)2025

Pharmacological Evaluation of Novel Hydrazide and Hydrazone Derivatives: Anti-Inflammatory and Analgesic Potential in Preclinical Models.

Hristina Zlatanova-Tenisheva, Stanislava Vladimirova

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hristina Zlatanova-TenishevaDepartment of Pharmacology and Clinical Pharmacology, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.ORCID 0000-0003-2555-4600
Stanislava VladimirovaDepartment of Organic Synthesis, University of Chemical Technology and Metallurgy, 1756 Sofia, Bulgaria.ORCID 0000-0002-2190-9980

Funding

European Union-NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria № BG-RRP-2.004-0002, "BiOrgaMCT"
6 · The paper itself

Abstract

Hydrazones, characterized by their C=N-NH functional group, are promising candidates in medicinal chemistry due to their ability to interact with biological targets. This study evaluated the anti-inflammatory and analgesic properties of

Indexed as

AnalgesicsAnti-Inflammatory AgentsHydrazinesHydrazonesAnimalsCarrageenanDisease Models, AnimalEdemaMaleRatsRats, WistarAnalgesicsAnti-Inflammatory AgentsCarrageenanHydrazinesHydrazonesformalin modelhydrazonespaw edemapaw withdrawaltail-flick

Identifiers

PMID40286066
PMCPMC11990862

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.